Cargando…

Global analysis of gene expression signature and diagnostic/prognostic biomarker identification of hepatocellular carcinoma

Hepatocellular carcinoma (HCC) is one of the most common cancers in the world. The landscape of HCC’s molecular alteration signature has been explored over the last few decades. Even so, more comprehensive research is still needed to improve understanding of tumorigenesis and progression of HCC, as...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Jihan, Wang, Yangyang, Xu, Jing, Song, Qiying, Shangguan, Jingbo, Xue, Mengju, Wang, Hanghui, Gan, Jingyi, Gao, Wenjie
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10450782/ https://www.ncbi.nlm.nih.gov/pubmed/34315286 http://dx.doi.org/10.1177/00368504211029429

Ejemplares similares

Identification of key biomarkers for STAD using filter feature selection approaches
por: Wang, Yangyang, et al.
Publicado: (2022)

Global Analysis of Microbiota Signatures in Four Major Types of Gastrointestinal Cancer
por: Wang, Jihan, et al.
Publicado: (2021)

Prognostic Biomarker Identification Through Integrating the Gene Signatures of Hepatocellular Carcinoma Properties
por: Cai, Jialin, et al.
Publicado: (2017)

Identification of a prognostic and therapeutic immune signature associated with hepatocellular carcinoma
por: Peng, Yanan, et al.
Publicado: (2021)

Identification and validation of a novel signature as a diagnostic and prognostic biomarker in colorectal cancer
por: Wang, Di, et al.
Publicado: (2022)

Identification of gene signatures for COAD using feature selection and Bayesian network approaches
por: Wang, Yangyang, et al.
Publicado: (2022)

GDI2 is a novel diagnostic and prognostic biomarker in hepatocellular carcinoma
por: Zhang, Wen, et al.
Publicado: (2021)

Comparison of hepatic and serum lipid signatures in hepatocellular carcinoma patients leads to the discovery of diagnostic and prognostic biomarkers
por: Lu, Yonghai, et al.
Publicado: (2017)

Identification of a prognostic signature and ENTR1 as a prognostic biomarker for colorectal mucinous adenocarcinoma
por: Huang, An, et al.
Publicado: (2023)

Exosomes and cancer - Diagnostic and prognostic biomarkers and therapeutic vehicle
por: Wang, Xia, et al.
Publicado: (2022)

Diagnostic and Prognostic Values of MANF Expression in Hepatocellular Carcinoma
por: He, Jingyi, et al.
Publicado: (2020)

Gut Microbiome Signature Are Correlated With Bone Mineral Density Alterations in the Chinese Elders
por: Wang, Yangyang, et al.
Publicado: (2022)

Identification of a Two-lncRNA Signature with Prognostic and Diagnostic Value for Hepatocellular Carcinoma
por: Liu, Huiying, et al.
Publicado: (2022)

A Novel Metabolism-Related Signature as a Candidate Prognostic Biomarker for Hepatocellular Carcinoma
por: Wang, Zhihao, et al.
Publicado: (2021)

Comprehensive analysis of an immune-related ceRNA network in identifying a novel lncRNA signature as a prognostic biomarker for hepatocellular carcinoma
por: Chen, Rui, et al.
Publicado: (2021)

Identification of Gene Signature as Diagnostic and Prognostic Blood Biomarker for Early Hepatocellular Carcinoma Using Integrated Cross-Species Transcriptomic and Network Analyses
por: Al-Harazi, Olfat, et al.
Publicado: (2021)

Identification of a Nine Immune-Related lncRNA Signature as a Novel Diagnostic Biomarker for Hepatocellular Carcinoma
por: Yuan, Mengqin, et al.
Publicado: (2021)

Serum-derived three-circRNA signature as a diagnostic biomarker for hepatocellular carcinoma
por: Sun, Xiang-Hong, et al.
Publicado: (2020)

Identification and Validation of Ubiquitin-Specific Proteases as a Novel Prognostic Signature for Hepatocellular Carcinoma
por: Ni, Wenkai, et al.
Publicado: (2021)

The Intratumor Microbiota Signatures Associate With Subtype, Tumor Stage, and Survival Status of Esophageal Carcinoma
por: Wang, Yangyang, et al.
Publicado: (2021)

ANP32 Family as Diagnostic, Prognostic, and Therapeutic Biomarker Related to Immune Infiltrates in Hepatocellular Carcinoma
por: Liu, Xuxu, et al.
Publicado: (2022)

A Novel Four-Gene Signature as a Potential Prognostic Biomarker for Hepatocellular Carcinoma
por: Wang, Guangfeng, et al.
Publicado: (2021)

Identification and validation a costimulatory molecule gene signature to predict the prognosis and immunotherapy response for hepatocellular carcinoma
por: Hu, Yinan, et al.
Publicado: (2022)

A novel seven-gene signature as Prognostic Biomarker in Hepatocellular Carcinoma
por: Xie, Hui, et al.
Publicado: (2020)

Novel Gene Signatures as Prognostic Biomarkers for Predicting the Recurrence of Hepatocellular Carcinoma
por: Son, Ju A, et al.
Publicado: (2022)

Prognostic Value of Cancer-Associated Fibroblast-Related Gene Signatures in Hepatocellular Carcinoma
por: Dong, Wenge, et al.
Publicado: (2022)

Promising Novel Biomarkers for Hepatocellular Carcinoma: Diagnostic and Prognostic Insights
por: Yu, James, et al.
Publicado: (2023)

Identification and Validation of a Prognostic lncRNA Signature for Hepatocellular Carcinoma
por: Li, Wang, et al.
Publicado: (2020)

An integrative analysis revealing cuproptosis-related lncRNAs signature as a novel prognostic biomarker in hepatocellular carcinoma
por: Chen, Xilang, et al.
Publicado: (2023)

Construction and Validation of Novel Diagnostic and Prognostic DNA Methylation Signatures for Hepatocellular Carcinoma
por: Li, Ran, et al.
Publicado: (2020)

A Novel Cuproptosis-Related Signature Identified DLAT as a Prognostic Biomarker for Hepatocellular Carcinoma Patients
por: Bai, Wen Dong, et al.
Publicado: (2022)

Identification of a Prognostic Transcriptome Signature for Hepatocellular Carcinoma with Lymph Node Metastasis
por: Ma, Jie, et al.
Publicado: (2022)

IgG N-glycan Signatures as Potential Diagnostic and Prognostic Biomarkers
por: Haslund-Gourley, Benjamin S., et al.
Publicado: (2023)

Identification of prognostic long non-coding RNA signature with potential drugs in hepatocellular carcinoma
por: Hao, Fengjie, et al.
Publicado: (2021)

Identification of a Novel Five-Gene Signature as a Prognostic and Diagnostic Biomarker in Colorectal Cancers
por: Ghatak, Souvik, et al.
Publicado: (2022)

Identification of prognostic and metastasis-related alternative splicing signatures in hepatocellular carcinoma
por: Huang, Runzhi, et al.
Publicado: (2020)

Identifying microbial signatures for patients with postmenopausal osteoporosis using gut microbiota analyses and feature selection approaches
por: Huang, Dageng, et al.
Publicado: (2023)

Identification of immune landscape signatures associated with clinical and prognostic features of hepatocellular carcinoma
por: Yan, Hongmei, et al.
Publicado: (2020)

METTL5 serves as a diagnostic and prognostic biomarker in hepatocellular carcinoma by influencing the immune microenvironment
por: Wang, Lei, et al.
Publicado: (2023)

A serum piRNA signature as promising non-invasive diagnostic and prognostic biomarkers for colorectal cancer
por: Qu, Ailin, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_i4rbdjc5u7hrk502vsqhibpqbk